Cargando…

Drug delivery strategy in hepatocellular carcinoma therapy

Hepatocellular carcinoma (HCC) is one of the most common malignant tumors worldwide, with high rates of recurrence and death. Surgical resection and ablation therapy have limited efficacy for patients with advanced HCC and poor liver function, so pharmacotherapy is the first-line option for those pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Sisi, Cai, Chengwei, Wang, Huanqiu, Ma, Xueqing, Shao, Anwen, Sheng, Jifang, Yu, Chengbo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8898478/ https://www.ncbi.nlm.nih.gov/pubmed/35248060 http://dx.doi.org/10.1186/s12964-021-00796-x

Ejemplares similares

Tenofovir Disoproxil Fumarate Is Superior to Entecavir in Reducing Hepatitis B Surface Antigen for Chronic Hepatitis B in China: 2-Year Comprehensive Comparative Result of a Matched Comparative Study
por: Yang, Sisi, et al.
Publicado: (2021)

Association between serum ferritin level and the various stages of non-alcoholic fatty liver disease: A systematic review
por: Wang, Huanqiu, et al.
Publicado: (2022)

Depression in sleep disturbance: A review on a bidirectional relationship, mechanisms and treatment
por: Fang, Hong, et al.
Publicado: (2019)

A novel scoring system in mortality prediction of severe patients with COVID-19
por: Shao, Anwen, et al.
Publicado: (2020)

Ketogenic Diets and Hepatocellular Carcinoma
por: Lan, Yan, et al.
Publicado: (2022)

Antibody-Drug Conjugates and Targeted Treatment Strategies for Hepatocellular Carcinoma: A Drug-Delivery Perspective
por: Dahlgren, David, et al.
Publicado: (2020)

Current epidemiological and clinical features of COVID-19; a global perspective from China
por: Tu, Huilan, et al.
Publicado: (2020)

Immunoreactive Cells After Cerebral Ischemia
por: Wang, Yijie, et al.
Publicado: (2019)

Drug Delivery and Therapy Strategies for Osteoporosis Intervention
por: Ma, Mingyang, et al.
Publicado: (2023)

Nanoparticle-Based Drug Delivery in Cancer Therapy and Its Role in Overcoming Drug Resistance
por: Yao, Yihan, et al.
Publicado: (2020)

Association between Non-Alcoholic Fatty Liver Disease and Intracerebral Hemorrhage
por: Tu, Sheng, et al.
Publicado: (2019)

Pathophysiology and Therapeutic Potential of NADPH Oxidases in Ischemic Stroke-Induced Oxidative Stress
por: Duan, Jinnan, et al.
Publicado: (2021)

Is Ferroptosis a Future Direction in Exploring Cryptococcal Meningitis?
por: Xu, Xianbin, et al.
Publicado: (2021)

Differentially Expressed Long Noncoding RNAs Involved in FUBP1 Promoting Hepatocellular Carcinoma Cells Proliferation
por: Li, Xianpeng, et al.
Publicado: (2021)

Development of nanoscale drug delivery systems of dihydroartemisinin for cancer therapy: A review
por: Wong, Ka Hong, et al.
Publicado: (2022)

Targeted therapy and personalized medicine in hepatocellular carcinoma: drug resistance, mechanisms, and treatment strategies
por: Galun, Danijel, et al.
Publicado: (2017)

Synergetic delivery of triptolide and Ce6 with light-activatable liposomes for efficient hepatocellular carcinoma therapy
por: Yu, Ling, et al.
Publicado: (2021)

Delivery strategies for macromolecular drugs in cancer therapy
por: Guo, Qin, et al.
Publicado: (2020)

Probing the drug delivery strategies in ischemic stroke therapy
por: Wu, Qiong, et al.
Publicado: (2020)

Crosstalk between stem cell and spinal cord injury: pathophysiology and treatment strategies
por: Shao, Anwen, et al.
Publicado: (2019)

Recent insights into the biological activities and drug delivery systems of tanshinones
por: Cai, Yuee, et al.
Publicado: (2016)

Ligand-based targeted therapy: a novel strategy for hepatocellular carcinoma
por: Li, Min, et al.
Publicado: (2016)

Dual-Targeting Nanoparticle-Mediated Gene Therapy Strategy for Hepatocellular Carcinoma by Delivering Small Interfering RNA
por: Zheng, Qi Chang, et al.
Publicado: (2020)

The improving strategies and applications of nanotechnology-based drugs in hepatocellular carcinoma treatment
por: Ren, Xiangyang, et al.
Publicado: (2023)

Statin-Based Palliative Therapy for Hepatocellular Carcinoma
por: Shao, Joni Yu-Hsuan, et al.
Publicado: (2015)

Identification and analysis of necroptosis-associated signatures for prognostic and immune microenvironment evaluation in hepatocellular carcinoma
por: Lu, Juan, et al.
Publicado: (2022)

Polymorphism in asparagine synthetase is associated with overall survival of hepatocellular carcinoma patients
por: Li, Wei, et al.
Publicado: (2017)

A magnetism/laser-auxiliary cascaded drug delivery to pulmonary carcinoma
por: Lin, Jialiang, et al.
Publicado: (2020)

Corrigendum: Dual-Targeting Nanoparticle-Mediated Gene Therapy Strategy for Hepatocellular Carcinoma by Delivering Small Interfering RNA
por: Zheng, Qi Chang, et al.
Publicado: (2021)

The Role of Ferroptosis in the Treatment and Drug Resistance of Hepatocellular Carcinoma
por: Zhao, Siqi, et al.
Publicado: (2022)

Successful stories of drug repurposing for cancer therapy in hepatocellular carcinoma
por: Attia, Yasmeen M., et al.
Publicado: (2020)

Locoregional Therapy Approaches for Hepatocellular Carcinoma: Recent Advances and Management Strategies
por: Makary, Mina S., et al.
Publicado: (2020)

Photodynamic therapy: A next alternative treatment strategy for hepatocellular carcinoma?
por: Zhu, Feng, et al.
Publicado: (2021)

A Calixarene Assembly Strategy of Combined Anti-Neuroinflammation and Drug Delivery Functions for Traumatic Brain Injury Therapy
por: Wang, Chunxiao, et al.
Publicado: (2022)

Current Strategies for the Treatment of Hepatocellular Carcinoma by Modulating the Tumor Microenvironment via Nano-Delivery Systems: A Review
por: Huang, Yongjie, et al.
Publicado: (2022)

Comprehensive analysis of long non-coding RNA expression profiles in hepatitis B virus-related hepatocellular carcinoma
por: Gong, Xianli, et al.
Publicado: (2016)

Synergistic Anticancer Strategy of Sonodynamic Therapy Combined with PI-103 Against Hepatocellular Carcinoma
por: Yang, Huajing, et al.
Publicado: (2021)

Early diagnosis and therapeutic strategies for hepatocellular carcinoma: From bench to bedside
por: Guan, Ming-Cheng, et al.
Publicado: (2021)

Strategies and Mechanism in Reversing Intestinal Drug Efflux in Oral Drug Delivery
por: Lu, Rong, et al.
Publicado: (2022)

Nanotechnology strategies for hepatocellular carcinoma diagnosis and treatment
por: Jia, WeiLu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_phife3v0cs03a22ioi1495qed2